Abbott Laboratories

Yahoo Finance • yesterday

2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income

Key Points These companies are leaders in their industries and well-positioned to deliver steady growth over time. They also offer dividend yields higher than that of the S&P 500. 10 stocks we like better than Coca-Cola › As an investor,... Full story

Yahoo Finance • 2 days ago

UBS spotlights 30 disrupters for the next decade

[3D Particle 30 Number Motion View with Fiery Hairlines on Blue Bokeh Background] Ketut Agus Suardika/iStock via Getty Images UBS has unveiled a curated list of 30 companies it believes are best positioned to thrive over the coming decade... Full story

Yahoo Finance • 3 days ago

Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. Ulti... Full story

Yahoo Finance • 3 days ago

The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout

Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an early entry. Continue Reading View Comments... Full story

Yahoo Finance • 4 days ago

USA Dietary Supplements Market Forecast and Company Analysis Report 2025-2033 Featuring Amway, Abbott, Glanbia, Bayer, Pfizer, Suntory, Herbalife, Haleon, Otsuka, Bountiful

Company Logo The United States Dietary Supplements Market, projected to grow from US$ 54.24 billion in 2024 to US$ 103.56 billion by 2033, is driven by rising health awareness and demand for preventive healthcare, alongside growing fitnes... Full story

Yahoo Finance • 5 days ago

Here’s Why Abbott Laboratories (ABT) Traded Down in Q3

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index continued its rally in the thi... Full story

Yahoo Finance • 6 days ago

A Look at Abbott Laboratories’s Valuation Following Revenue Growth and Maintained Outlook

Abbott Laboratories (ABT) just released its quarterly results, revealing revenue grew nearly 7% over last year, though it missed Wall Street estimates. The company kept its full-year outlook intact and narrowed adjusted EPS guidance. See... Full story

Yahoo Finance • 6 days ago

How Investors May Respond To Abbott (ABT) Missing Q3 Revenue Targets While Reaffirming Outlook and Buying Back Shares

In the past week, Abbott Laboratories reported its third quarter 2025 results, showing revenue up 6.9% year over year but missing Wall Street expectations and reaffirming its full-year outlook, while also completing the repurchase of more... Full story

Yahoo Finance • 7 days ago

Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Cadrenal Therapeutics Inc. PONTE VEDRA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation the... Full story

Yahoo Finance • 8 days ago

10 Defensive Stocks with Market-Beating Yields

It’s been a great year for stocks, but in the past few days the bull market seems to have lost some of its mojo. Continue Reading View Comments... Full story

Yahoo Finance • 9 days ago

Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030

BCC Research LLC "Driven by Technological Advances and Expanding Clinical Applications, Patient Monitoring Devices Are Revolutionizing Healthcare Delivery Across Hospitals, Home Care, and Remote Settings" Boston, Nov. 07, 2025 (GLOBE NEW... Full story

Yahoo Finance • 11 days ago

Has Abbott Stock’s Valuation Shifted With Expanded FDA Approvals in 2025?

Wondering if Abbott Laboratories is undervalued, fairly priced, or perhaps even a hidden bargain? You are not alone, as many investors are taking a closer look at this healthcare giant. The stock is up 9.8% year-to-date, despite a recent 6... Full story

Yahoo Finance • 11 days ago

Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc.

This article first appeared on GuruFocus. Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Warning! GuruFocus has detected 4 Warning Sign with AIG. Is AIG fairly valued? Test your thesis with our free DC... Full story

Yahoo Finance • 14 days ago

HbA1c Testing Market Research Report 2025-2033, Profiles of Key Players - Danaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics

Company Logo The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing technologies. Supportive healthcare initiatives and increased awareness enhance demand. Strategic insights, co... Full story

Yahoo Finance • 17 days ago

Abbott Showcases World’s First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV

D S Simon Boston Teacher Shares Life-Changing Experience with Breakthrough Dual Chamber Leadless Pacemaker During Nationwide Interviews in Conjunction with D S Simon Media Boston Teacher Shares Life-Changing Experience with Breakthrough... Full story

Yahoo Finance • 19 days ago

t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States

The t:slim X2™ Insulin Pump with Abbott’s FreeStyle Libre® 3 Plus Sensor is now available in the United States, beginning global commercial rollout. Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with... Full story

Yahoo Finance • 20 days ago

Abbott Laboratories (NYSE:ABT) Shares Could Be 33% Above Their Intrinsic Value Estimate

Key Insights The projected fair value for Abbott Laboratories is US$95.46 based on 2 Stage Free Cash Flow to Equity Current share price of US$127 suggests Abbott Laboratories is potentially 33% overvalued The US$144 analyst price target f... Full story

Yahoo Finance • 21 days ago

Cardiovascular Repair & Reconstruction Devices - Global Market Forecast (2025-2032) Featuring Profiles of Medtronic, Edwards Lifesciences, Abbott Labs, Boston Scientific, Terumo and More

Company Logo The cardiovascular repair market is fueled by an aging population, technological advancements, and the rise in comorbidities. Opportunities lie in innovative, minimally invasive devices, value-based contracting, and regional... Full story

Yahoo Finance • 21 days ago

Goldman Sachs Still Says Sell-Off Coming – 5 Safe Conviction List Picks

Chaay_Tee / iStock via Getty Images Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue. The Wall St... Full story

Yahoo Finance • 24 days ago

Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio

This article first appeared on GuruFocus. Insights into Eaton Vance's Strategic Moves in the Healthcare Sector Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2... Full story